CLBT – cellebrite di ltd. - ordinary shares (US:NASDAQ)
Stock Stats
News
Cellebrite Files its 2024 Annual Report on Form 20-F
Cellebrite DI Ltd. (NASDAQ: CLBT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $28.00 price target on the stock.
Greenhaven Road Capital: Cellebrite (CLBT) has a Decade-Long History of Growing Quickly and Profitably [Yahoo! Finance]
SMGZY or CLBT: Which Is the Better Value Stock Right Now? [Yahoo! Finance]
Cellebrite DI Ltd. (NASDAQ:CLBT) Just Reported And Analysts Have Been Lifting Their Price Targets [Yahoo! Finance]
Form 144 Cellebrite DI Ltd. Filed by: Ben-Peretz Leeor
Form 20-F Cellebrite DI Ltd. For: Dec 31
Form 144 Cellebrite DI Ltd. Filed by: Carmil Yosef
Form 144 Cellebrite DI Ltd. Filed by: Ben-Peretz Leeor
Form 144 Cellebrite DI Ltd. Filed by: Gruber Dafna
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.